Clinical Trial Update: A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reports completion of a Phase 1 study of VSA003 in Chinese adult healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Familial Hypercholesterolemia
• Hypertriglyceridemia

Drugs mentioned

• VSA003

Snippet

Sponsor: Visirna Therapeutics HK Limited | Conditions: Dyslipidemias, Familial Hypercholesterolemia | Phase 1 | Status: COMPLETED